BRPI0407073A - ésteres de ácido carboxìlico de compostos farmacêuticos - Google Patents

ésteres de ácido carboxìlico de compostos farmacêuticos

Info

Publication number
BRPI0407073A
BRPI0407073A BR0407073-9A BRPI0407073A BRPI0407073A BR PI0407073 A BRPI0407073 A BR PI0407073A BR PI0407073 A BRPI0407073 A BR PI0407073A BR PI0407073 A BRPI0407073 A BR PI0407073A
Authority
BR
Brazil
Prior art keywords
carboxylic acid
acid esters
pharmaceutical compounds
cooh
group
Prior art date
Application number
BR0407073-9A
Other languages
English (en)
Inventor
Gerd Ascher
Klaus Thirring
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of BRPI0407073A publication Critical patent/BRPI0407073A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"éSTERES DE áCIDO CARBOXìLICO DE COMPOSTOS FARMACêUTICOS". A presente invenção refere-se a um composto farmaceuticamente ativo tendo um grupo ácido carboxílico -COOH como parte de sua estrutura química, cujo grupo -COOH está na forma de um éster de ácido carboxílico.
BR0407073-9A 2003-01-28 2004-01-27 ésteres de ácido carboxìlico de compostos farmacêuticos BRPI0407073A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0301938.7A GB0301938D0 (en) 2003-01-28 2003-01-28 Organic compounds
PCT/EP2004/000683 WO2004067536A2 (en) 2003-01-28 2004-01-27 Carboxylic acid esters to improve bioavailability of pharmaceutical compounds

Publications (1)

Publication Number Publication Date
BRPI0407073A true BRPI0407073A (pt) 2006-01-24

Family

ID=9951957

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0407073-9A BRPI0407073A (pt) 2003-01-28 2004-01-27 ésteres de ácido carboxìlico de compostos farmacêuticos

Country Status (10)

Country Link
US (1) US20060122164A1 (pt)
EP (1) EP1590354A2 (pt)
JP (1) JP2006515633A (pt)
CN (1) CN1745086A (pt)
AR (1) AR042929A1 (pt)
BR (1) BRPI0407073A (pt)
CA (1) CA2509793A1 (pt)
GB (1) GB0301938D0 (pt)
TW (1) TW200504080A (pt)
WO (1) WO2004067536A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR040545A1 (es) * 2002-07-15 2005-04-13 Sandoz Ag Cefalosporinas
DK3532057T3 (da) 2016-10-31 2023-02-20 Biocryst Pharm Inc Prodrugs af kallikreininhibitorer
CN112703003A (zh) * 2018-08-02 2021-04-23 纯技术Lyt股份有限公司 孕烷神经类固醇的脂质前药及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458772B1 (en) * 1909-10-07 2002-10-01 Medivir Ab Prodrugs
GB1426717A (en) * 1972-03-13 1976-03-03 Astra Laekemedel Ab Penicillins
GB1598568A (en) * 1977-04-19 1981-09-23 Glaxo Lab Ltd Esters of(6r,7r)-3-carbamoyloxymethyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid
US4486425A (en) * 1980-09-30 1984-12-04 Sankyo Company Limited 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-methoxymethyl-3-cephem-4-carboxylates
US4874856A (en) * 1985-06-24 1989-10-17 Bristol-Myers Company 3-(substituted)propenyl-7-(aminothiazolylacetamido) ceph-3-em-4-carboxylic acids and esters thereof
JP2000239275A (ja) * 1998-12-25 2000-09-05 Sankyo Co Ltd カルバペネムエステル誘導体

Also Published As

Publication number Publication date
CN1745086A (zh) 2006-03-08
WO2004067536A2 (en) 2004-08-12
US20060122164A1 (en) 2006-06-08
JP2006515633A (ja) 2006-06-01
TW200504080A (en) 2005-02-01
EP1590354A2 (en) 2005-11-02
AR042929A1 (es) 2005-07-06
WO2004067536A3 (en) 2004-12-23
GB0301938D0 (en) 2003-02-26
CA2509793A1 (en) 2004-08-12

Similar Documents

Publication Publication Date Title
HRP20050641A2 (en) New carboxylic acids and the esters thereof, pharmaceutical compositions containing these compounds and processes for the preparation thereof
ATE429416T1 (de) Cyanophenoxy-carbonsäuren und zusammensetzungen für die freisetzung aktiver substanzen
FR2884818B1 (fr) Procede de preparation d'acide acrylique a partir de glycerol
JP2003506345A5 (pt)
WO2005107719A3 (en) Pharmaceutical composition comprising hydrophobic drug having improved solubility
IL190905A0 (en) 4-alkoxy cyclohexane-1-amino carboxylic acids and processes for their prepatation
ECSP034850A (es) Sal citrato de 5, 8, 14-triazatetraciclo [10.3.1.02,11.04,9] hexadeca-2 (11),3,5,7,9-pentaeno y composiciones farmaceuticas de la misma
BR0112584A (pt) ésteres oxigenados de ácidos benzidroxâmicos de 4-iodofenilamino
UY27320A1 (es) Nuevas composiciones farmacéuticas
BRPI0507617A (pt) antagonistas de receptor de quimiocina
HRP20080027T3 (en) 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
EP2682387A3 (en) C7-fluoro substituted tetracycline compounds
EG25480A (en) Method for preparation of optionally 2-substituted1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acids
CR9993A (es) Formulación de suspensión de fexofenadina
NO20024241L (no) FremgangsmÕte for fremstilling av citalopram
ATE455761T1 (de) Neue atorvastatinsalze und pharmazeutische zusammensetzungen, die diese enthalten
BR0311642A (pt) Formulação de divalproex de sódio de liberação aumentada
BRPI0407073A (pt) ésteres de ácido carboxìlico de compostos farmacêuticos
ATE464043T1 (de) Pharmazeutische zusammensetzung enthaltend l- arginin
BR0114156A (pt) Forma amorfa de inibidor de ciclo de célula
WO2001081298A3 (en) Cyclic carboxylic acids as integrin antagonists
ITMI20030063A1 (it) Cloridrato monoidrato dell'estere (6-dietilamminometil-naftalen-2-il)metilico dell'acido (4-idrossicarbammoil-fenil)carbammico.
AU8294401A (en) A process for the preparation of alpha' chloroketones
ATE275577T1 (de) Quinapril magnesium enthaltende, pharmazeutisch wirksame zusammensetzung
BR9909029A (pt) Estabilização de poliisocianatos orgânicos

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]